Mary Cushman Spoke with WPTZ About New Research Showing Incidence of Cognitive Impairment Prediction
Mary Cushman, University Distinguished Professor and Vice Chair at University of Vermont, shared her first post on LinkedIn:
“My 1st LinkedIn post!
I was pleased to speak with WPTZ about our new research showing that circulating laboratory markers of neurodegeneration can predict the incidence of cognitive impairment over 12 years in initially healthy people.
It is amazing to me that damage to the brain can be detected in the blood, and detect pathology occurring years before cognitive problems start.
Associations were larger than I thought they’d be.
This research comes from the REGARDS Study, which we have been conducting since 2003.”
Title: Circulating Biomarkers of Neurodegeneration and Risk of Cognitive Impairment
Authors: Russell P. Sawyer, Aleena Bennett, Jessica Blair, Suzanne E. Judd, Nels Olson, Virginia J. Howard, Nicole D. Armstrong, D. Leann Long, Hyacinth I. Hyacinth, Jennifer J. Manly, Mary Cushman
Read full paper here.
Never miss the latest with Hemostasis Today.
-
Dec 6, 2025, 18:02ASH25 Day 1: Don’t Miss The Highlights
-
Dec 6, 2025, 15:44Atul Gupta on Where The Healthcare Innovation is Headed
-
Dec 6, 2025, 15:22Nathan White on How Inflammation Contributes to Coagulopathy After Trauma
-
Dec 6, 2025, 15:02Anas Younes on AstraZeneca’s Aims in Blood Cancer to Be Presented at ASH25
-
Dec 6, 2025, 14:08David Alderman: ASH25 is Live
-
Dec 6, 2025, 13:53Isabelle Mahé Presents The Proposals from INNOVTE CAT Working Group
-
Dec 6, 2025, 11:50Steve Tuplin on Roche’s Mission at ASH25
-
Dec 6, 2025, 11:13Khaled Musallam on The Lancet Haematology Podcast: Your ASH25 Roadmap
-
Dec 5, 2025, 03:46Sreeni Sivan Pillai: Preventing Thrombophlebitis and Upper Limb DVT in PICC Lines